SCHEMBL13575656

SCHEMBL13575656

C=N/C=C\N(N)c1ncc(OC)c2c(C(=O)C(=O)N3CCn4c(-c5ccccc5)cnc4C3)c[nH]c12

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.48
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C8 P10632 1/20 0.44
CYP2B6 P20813 1/20 0.44
CYP2C19 P33261 1/20 0.44
KCNH2 Q12809 1/20 0.44
P2RX7 Q99572 9/20 0.40
PDK2 Q15119 1/20 0.39
HDAC1 Q13547 2/20 0.36
HDAC4 P56524 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
PDE7B Q9NP56 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13575652 0.90 CYP2C9 (0.48) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL10095066 0.83 CYP2C9 (0.54) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL10095022 0.81 CYP2C9 (0.51) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL10094986 0.79 CYP2C9 (0.50) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL10094979 0.79 CYP3A4 (0.72) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL13575650 0.79 P2RX7 (0.40) CYP2C9CYP2D6CYP1A2CYP2C19P2RX7
SCHEMBL10094981 0.78 CYP3A4 (0.54) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL9914969 0.78 CYP2C9 (0.41) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL12625715 0.78 CYP2C9 (0.46) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL9914925 0.77 CYP2C9 (0.47) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009158394-A1 DIKETO AZOLOPIPERIDINES AND AZOLOPIPERAZINES AS ANTI-HIV AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-12-30 WO disclosed